Abstract:An organ-on-a-chip is a microfluidic device that simulates the microenvironment of organs, facilitating the study of human physiology and disease mechanisms. Through the integration of tissue engineering and micromachining technologies, it effectively manages the cellular microenvironment and implements tissue-specific functions and physiological responses with high fidelity. Several factors must be appropriately considered in the fabrication of an organ-on-a-chip, including the choice of biomaterials to simulate the extracellular matrix (ECM), selection of cells constituting the target organ, incorporation of humanized design to realize the primary function and structure of the organ, and the use of appropriate biofabrication methods to build a tissue-specific environment. Notably, three-dimensional (3D) bioprinting has emerged as a promising method for biofabricating organ-on-a-chip. Three-dimensional bioprinting offers versatility in adapting to various biomaterials with different physical properties, allowing precise control of 3D cell arrays and facilitating cyclic movements of fluidic flow within microfluidic platforms. These capabilities enable the precise fabrication of organ-on-a-chip that reflects tissue-specific functions and microenvironments. Additionally, 3D-bioprinted organ-on-a-chip can serve as a disease-on-a-chip platform, achieved through the implementation of pathophysiological environments and integration with devices such as bioreactors. Their significance in pharmacology research lies in their exceptional resemblance to the 3D microenvironment structure of actual organs, which are conducive for the validation of sequential mechanism of drug action. This review describes recent examples of organ-on-a-chip applications for various organs and state-of-the-art 3D bioprinting techniques employed in organ-on-a-chip fabrication. The discussion extends to the future prospects of this technology, encompassing aspects such as commercialization through mass production and its potential application in personalized medicine or drug-screening platforms. Serving as a relevant guide, this review offers insights for future research and developments in in vitro micromodel fabrication.

Bioprinting of three-dimensional culture models and organ-on-a-chip systems

3D Bioprinting: A Novel Avenue for Manufacturing Tissues and Organs

The Emergence of 3D Bioprinting in Organ-on-chip Systems

Application of biomaterial-based three-dimensional bioprinting for organ-on-a-chip fabrication

Simultaneous Multimaterial Multimethod Bioprinting

3D Bioprinting: an Emerging Technology Full of Opportunities and Challenges

Grafting of 3D Bioprinting to in Vitro Drug Screening: A Review

Three-dimensional bioprinting of in vitro tumor organoid and organ-on-a-chip models

Three-Dimensional Bioprinting of Organoids: Past, Present, and Prospective

3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling.

3D bioprinting for organ and organoid models and disease modeling

3D Bioprinting for Tissue and Organ Fabrication

3D‐Bioprinting for Precision Microtissue Engineering: Advances, Applications, and Prospects

3D bioprinted organ‐on‐chips

A Multifunctional 3D Bioprinting System for Construction of Complex Tissue Structure Scaffolds: Design and Application

Perspective: Fabrication of Integrated Organ-on-a-chip Via Bioprinting.

Developments and Opportunities for 3D Bioprinted Organoids

3D Bioprinting of Organoids: past, present, and prospective

3D Bioprinting for Next-Generation Personalized Medicine

Patient‐Specific Organoid and Organ‐on‐a‐Chip: 3D Cell‐Culture Meets 3D Printing and Numerical Simulation

Organoid bioprinting strategy and application in biomedicine: A review